Kevin M. Harter

NanoHorizons, Inc. designs and manufactures advanced nanoscale silver additives. The firm manufactures advanced nanoparticles for integration in a broad range of consumer, commercial and industrial products to provide permanent, effective anti-bacterial, antifungal, antiviral and performance enhancing characteristics. The company was founded by Joseph D. Cuiffi, Stephen J. Fonash, Daniel Hayes and Ali Kaan Kalkan in 2002 and is headquartered in Bellefonte, PA.

Hanson Technologies, Inc. provides biosensing solutions for food pathogen screening. Its technology solutions have multiple applications including food safety testing, blood diagnostics, and agricultural testing. The company was founded on January 9, 2003 and is headquartered in Carlisle, PA

Saladax Biomedical, Inc. develops novel and commercializes diagnostic assays for the practical delivery of personalized medicine. Its products include pipeline, MY5-FU, mypaclitaxel, and mydocetaxel. MyCare product serves the central nervous system field, with antipsychotic drug dose management assays. The company was founded by Adrienne Choma and Salvatore J. Salamone in 2004 and is headquartered in Bethlehem, PA.

Pennsylvania Blue Shield provides healthcare insurance coverage. The private company is based in Camp Hill, PA.

Part of Datavant, Inc., Keystone Medical Systems, Inc. is a physician management system. The company is based in Lemoyne, PA. Keystone Medical Systems was acquired by Companion Technologies Corp. on September 19, 1996. The company was founded by Kevin M. Harter.

Life Sciences Greenhouse of Central Pennsylvania (LSGPA) is a venture capital firm founded by Kevin M. Harter in 2002. The firm is headquartered in Harrisburg, Pennsylvania.

ProSanos Corp. develops and provides healthcare solutions for the pharmaceutical and biotechnology industries. The company was founded by Jonathan A. Morris and Michael N. Liebman in 2000 and is headquartered in Harrisburg, PA.

Ras Therapeutics, Inc. develops therapies for cancer. Its products are used to treat pancreatic and other cancers with new treatment options and the advancement of clinical trials methodologies. The company was founded by Richard N. Kolesnick in 2006 and is headquartered in Harrisburg, PA.